All of the above implies if pregnancy is complicated with diabetes, hypertension and/or autoimmune diseases, sFlt-1/PlGF and PlGF% rather than PlGF and sFlt-1 alone should be preferred as biomarkers in helping screening out pregnancy that will deliver small-for-gestational age and/or low birth weight neonates. Here, PGF is linked to diabetes mellitus.